JANETTE MCDOUGALL: Open Payments
NPI 1134764012 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,860 in 80 payments from 18 companies in 2025. Trend: 2023 $623 · 2024 $1,346 · 2025 $1,860
Food & beverage: $1,756Education: $60Consulting: $44
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $264 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $224 |
| Regeneron Healthcare Solutions, Inc. | 14 | $194 |
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| Pharming Healthcare, Inc. | 6 | $150 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $142 |
| BioCryst US Sales Co., LLC | 5 | $134 |
| ABBVIE INC. | 1 | $113 |
| Cycle Pharmaceuticals Inc | 4 | $96 |
| GENZYME CORPORATION | 2 | $73 |
Products named: DUPIXENT, NUCALA, RUCONEST, NEFFY, ORLADEYO, BOTOX, TRELEGY ELLIPTA, XOLAIR.
Industry payments across NV — which companies pay providers there.
